Article info
PDFClinical and epidemiological research
Concise report
Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab
- Correspondence to Falk Hiepe, Department of Medicine, Clinic for Rheumatology and Clinical Immunology, Charité–Universitätsmedizin Berlin and German Rheumatism Research Center Berlin-Leibniz Institute, Charitéplatz 1, D-10117 Berlin, Germany; falk.hiepe{at}charite.de
Citation
Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab
Publication history
- Accepted August 3, 2011
- First published September 27, 2011.
Online issue publication
November 30, 2011
Article Versions
- Previous version (27 September 2011).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions